These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 8466553)
1. Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines. Liu X; Engelman RM; Wei Z; Bagchi D; Rousou JA; Nath D; Das DK Biochem Pharmacol; 1993 Mar; 45(6):1333-41. PubMed ID: 8466553 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and antiischemic effects of nifedipine, lacidipine, and nisoldipine in rat isolated working heart. Pijl AJ; Pfaffendorf M; van Zwieten PA J Cardiovasc Pharmacol; 1993 Sep; 22(3):381-7. PubMed ID: 7504127 [TBL] [Abstract][Full Text] [Related]
3. Reduction of myocardial ischemic reperfusion injury by sialylated glycosphingolipids, gangliosides. Maulik N; Das DK; Gogineni M; Cordis GA; Avrova N; Denisova N J Cardiovasc Pharmacol; 1993 Jul; 22(1):74-81. PubMed ID: 7690100 [TBL] [Abstract][Full Text] [Related]
4. Normothermic cardioplegia prevents intracellular calcium accumulation during cardioplegic arrest and reperfusion. Liu X; Engelman RM; Rousou JA; Flack JE; Deaton DW; Das DK Circulation; 1994 Nov; 90(5 Pt 2):II316-20. PubMed ID: 7955273 [TBL] [Abstract][Full Text] [Related]
5. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion? Ehring T; Heusch G Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166 [TBL] [Abstract][Full Text] [Related]
6. Ventricular function and calcium handling during ischemia. Amende I; Bentivegna L; Morgan JP J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S42. PubMed ID: 1282612 [TBL] [Abstract][Full Text] [Related]
7. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release. Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834 [TBL] [Abstract][Full Text] [Related]
8. Antioxidant properties of dihydropyridines in isolated rat hearts. Kauder WF; Watts JA Biochem Pharmacol; 1996 Mar; 51(6):811-9. PubMed ID: 8602877 [TBL] [Abstract][Full Text] [Related]
9. Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridine. Segawa D; Sjöquist PO; Nordlander M; Wang QD; Gonon A; Rydén L Eur J Pharmacol; 1999 Sep; 380(2-3):123-8. PubMed ID: 10513571 [TBL] [Abstract][Full Text] [Related]
10. ATP-dependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury. Zhu HF; Dong JW; Zhu WZ; Ding HL; Zhou ZN Life Sci; 2003 Jul; 73(10):1275-87. PubMed ID: 12850243 [TBL] [Abstract][Full Text] [Related]
11. Propofol improves cardiac functional recovery after ischemia-reperfusion by upregulating nitric oxide synthase activity in the isolated rat hearts. Sun HY; Xue FS; Xu YC; Li CW; Xiong J; Liao X; Zhang YM Chin Med J (Engl); 2009 Dec; 122(24):3048-54. PubMed ID: 20137500 [TBL] [Abstract][Full Text] [Related]
12. Effects of sustained low-flow ischemia and reperfusion on Ca2+ transients and contractility in perfused rat hearts. Seki S; Horikoshi K; Takeda H; Izumi T; Nagata A; Okumura H; Taniguchi M; Mochizuki S Mol Cell Biochem; 2001 Jan; 216(1-2):111-9. PubMed ID: 11216855 [TBL] [Abstract][Full Text] [Related]
13. Intracellular calcium and ventricular function. Effects of nisoldipine on global ischemia in the isovolumic, coronary-perfused heart. Amende I; Bentivegna LA; Zeind AJ; Wenzlaff P; Grossman W; Morgan JP J Clin Invest; 1992 Jun; 89(6):2060-5. PubMed ID: 1602012 [TBL] [Abstract][Full Text] [Related]
14. Prevention of transcoronary macromolecular leakage after ischemia-reperfusion by the calcium entry blocker nisoldipine. Direct observations in isolated rat hearts. McDonagh PF; Roberts DJ Circ Res; 1986 Jan; 58(1):127-36. PubMed ID: 3080259 [TBL] [Abstract][Full Text] [Related]
15. Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. Kalfin R; Maulik N; Engelman RM; Cordis GA; Milenov K; Kasakov L; Das DK J Pharmacol Exp Ther; 1994 Feb; 268(2):952-8. PubMed ID: 8114010 [TBL] [Abstract][Full Text] [Related]
17. Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion. Becker BF; Möbert J Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):287-94. PubMed ID: 10543430 [TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects of amlodipine in the ischemic-reperfused heart. Hoff PT; Tamura Y; Lucchesi BR Am J Cardiol; 1989 Nov; 64(17):101I-115I discussion 115I-116I. PubMed ID: 2530882 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of the cardiac Na+/Ca2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Cross HR; Lu L; Steenbergen C; Philipson KD; Murphy E Circ Res; 1998 Dec 14-28; 83(12):1215-23. PubMed ID: 9851938 [TBL] [Abstract][Full Text] [Related]